The role of interleukin-10 in severe acute alcoholic hepatitis

Clinical Biochemistry

Volumn 34, Issue 3, 2001, Pages 237-238

  Taïeb, Julien ^a,b   Chollet Martin, Sylvie ^b   Cohard, Marielle ^c   Jacques Garaud, Jean ^c   Poynard, Thierry ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CONCANAVALIN A; CORTICOSTEROID DERIVATIVE; CYTOKINE; ENDOTOXIN; GALACTOSAMINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROTEINASE; REACTIVE OXYGEN METABOLITE; SELECTIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; CELL ACTIVATION; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EXTRACELLULAR MATRIX; HUMAN; LEUKOCYTE; LIPID PEROXIDATION; LIVER CELL; LIVER FAILURE; LIVER INJURY; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME; TISSUE INJURY; TREATMENT OUTCOME;

ACUTE DISEASE; HEPATITIS, ALCOHOLIC; HUMANS; INTERLEUKIN-10; RECOMBINANT PROTEINS;

EID: 0034971845     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(01)00211-9     Document Type: Article

References (24)

1. Alcoholic hepatitis: Pathogenesis and approaches to treatment
2. Corticosteroids improve short term survival in patients with severe alcoholic hepatitis: Individual data analysis of the last three randomised placebo controlled double blind trials
3. Cellular signals in alcohol-induced liver injury: A review
4. Neutrophil-derived proteins: Selling cytokines by the pound
5. Oxydants from phagocytes: Agents of defense and destruction
6. Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: Effect of corticosteroids
7. Plasma tumor necrosis factor α predicts decreased long-term survival in severe alcoholic hepatitis
8. Circulating and tissue levels of the neutrophil chemotaxin IL8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration
9. Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice
10. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release
11. Anti-inflammatory cytokine responses during clinical sepsis, and experimental endotoxemia: Sequencial measurements of plasma soluble IL1 receptor type II, IL10, and IL13
12. IL-10 differentially regulates cytokine inhibitor, and chemokine release from blood mononuclear cells, and fibroblasts
13. Interleukin-10
14. Clinical, hematologic, and immunologic effects of interleukin-10 in humans
15. Systemic release of interleukin-10 during orthotopic liver transplantation
16. Production and role of interleukin 10 in concanavalin A induced hepatitis in mice
17. Hepatoprotective role of interleukin 10 in galactosaminee/lipopolysaccharide mouse liver injury
18. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice
19. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor kappaB
20. Interleukin-10 expression, and function in experimental murine liver inflammation, and fibrosis
21. Interleukin 10 promoter region polymorphisms, and susceptibility to advanced alcoholic liver disease
22. Role of defective monocyte IL-10 release in TNFα overproduction in alcoholic cirrhosis
23. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
24. A randomized control trial of IL10 in humans. Inhibition of inflammatory cytokine production and immune responses